Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 7174127, 13 pages
http://dx.doi.org/10.1155/2016/7174127
Research Article

Metallothioneins 1 and 2 Modulate Inflammation and Support Remodeling in Ischemic Cardiomyopathy in Mice

1Department of Cardiac Surgery, University Clinical Center, Rheinische Friedrich-Wilhelms-Universität Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany
2Department of Anesthesiology, University Clinical Center, Rheinische Friedrich-Wilhelms-Universität Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany
3Department of Ophthalmology, University Clinical Center, Rheinische Friedrich-Wilhelms-Universität Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany
4Department of General, Visceral, Thoracic and Vascular Surgery, University Clinical Center, Rheinische Friedrich-Wilhelms-Universität Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany
5Department of Medicine II-Cardiology, University Clinical Center, Rheinische Friedrich-Wilhelms-Universität Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany

Received 18 March 2016; Accepted 4 May 2016

Academic Editor: Constantino López-Macías

Copyright © 2016 Georg D. Duerr et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. G. Frangogiannis, S. Shimoni, S. Chang et al., “Active interstitial remodeling: an important process in the hibernating human myocardium,” Journal of the American College of Cardiology, vol. 39, no. 9, pp. 1468–1474, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Kloner, R. Bolli, E. Marban, L. Reinlib, and E. Braunwald, “Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop,” Circulation, vol. 97, no. 18, pp. 1848–1867, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Dewald, N. G. Frangogiannis, M. Zoerlein et al., “Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 5, pp. 2700–2705, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. N. G. Frangogiannis, O. Dewald, Y. Xia et al., “Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy,” Circulation, vol. 115, no. 5, pp. 584–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. D. Duerr, J. C. Heinemann, G. Suchan et al., “The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy,” Basic Research in Cardiology, vol. 109, no. 4, article 425, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. G. D. Duerr, B. Mesenholl, J. C. Heinemann et al., “Cardioprotective effects of osteopontin-1 during development of murine ischemic cardiomyopathy,” BioMed Research International, vol. 2014, Article ID 124063, 15 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. D. U. Spahl, D. Berendji-Grün, C. V. Suschek, V. Kolb-Bachofen, and K.-D. Kröncke, “Regulation of zinc homeostasis by inducible NO synthase-derived NO: nuclear metallothionein translocation and intranuclear Zn2+ release,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 13952–13957, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. K.-I. Inoue, H. Takano, A. Shimada, and M. Satoh, “Metallothionein as an anti-inflammatory mediator,” Mediators of Inflammation, vol. 2009, Article ID 101659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. J. Kang, G. Li, and J. T. Saari, “Metallothionein inhibits ischemia-reperfusion injury in mouse heart,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 276, no. 3, pp. H993–H997, 1999. View at Google Scholar · View at Scopus
  10. Y. J. Kang, Y. Li, X. Sun, and X. Sun, “Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice,” The American Journal of Pathology, vol. 163, no. 4, pp. 1579–1586, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Yang, J.-Y. Gao, J. Ma et al., “Cardiac-specific overexpression of metallothionein attenuates myocardial remodeling and contractile dysfunction in l-NAME-induced experimental hypertension: role of autophagy regulation,” Toxicology Letters, vol. 237, no. 2, pp. 121–132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Oshima, Y. Fujio, T. Nakanishi et al., “STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart,” Cardiovascular Research, vol. 65, no. 2, pp. 428–435, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Zhou, X. Yin, Y. Zheng et al., “Metallothionein prevents intermittent hypoxia-induced cardiac endoplasmic reticulum stress and cell death likely via activation of Akt signaling pathway in mice,” Toxicology Letters, vol. 227, no. 2, pp. 113–123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Fu, J. Guo, L. Jing, R. Li, T. Zhang, and S. Peng, “Enhanced toxicity and ROS generation by doxorubicin in primary cultures of cardiomyocytes from neonatal metallothionein-I/II null mice,” Toxicology in Vitro, vol. 24, no. 6, pp. 1584–1591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. B. A. Masters, E. J. Kelly, C. J. Quaife, R. L. Brinster, and R. D. Palmiter, “Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 2, pp. 584–588, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. T. O. Nossuli, V. Lakshminakayanan, G. Baumgarten et al., “A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 278, no. 4, pp. H1049–H1055, 2000. View at Google Scholar · View at Scopus
  17. G. D. Duerr, O. Dewald, N. Elhafi et al., “Comparison of myocardial remodeling between cryoinfarction and reperfused infarction in mice,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 961298, 10 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Velten, G. D. Duerr, T. Pessies et al., “Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice,” Cardiovascular Research, vol. 96, no. 3, pp. 422–432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. G. D. Duerr, J. C. Heinemann, V. Arnoldi et al., “Cardiomyocyte specific peroxisome proliferator-activated receptor-α overexpression leads to irreversible damage in ischemic murine heart,” Life Sciences, vol. 102, no. 2, pp. 88–97, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. N. G. Frangogiannis, L. H. Michael, and M. L. Entman, “Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb),” Cardiovascular Research, vol. 48, no. 1, pp. 89–100, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Dewald, S. Sharma, J. Adrogue et al., “Downregulation of peroxisome proliferator-activated receptor-α gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity,” Circulation, vol. 112, no. 3, pp. 407–415, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Erlanson-Albertsson, “The role of uncoupling proteins in the regulation of metabolism,” Acta Physiologica Scandinavica, vol. 178, no. 4, pp. 405–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. J. Kang, “The antioxidant function of metallothionein in the heart,” Experimental Biology and Medicine, vol. 222, no. 3, pp. 263–273, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Waeytens, M. De Vos, and D. Laukens, “Evidence for a potential role of metallothioneins in inflammatory bowel diseases,” Mediators of Inflammation, vol. 2009, Article ID 729172, 9 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Meng, Z. Su, Z. Liu, N. Wang, and Z. Wang, “Rac1 contributes to cerebral ischemia reperfusion-induced injury in mice by regulation of Notch2,” Neuroscience, vol. 306, pp. 100–114, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Mita, M. Satoh, A. Shimada et al., “Metallothionein is a crucial protective factor against Helicobacter pylori-induced gastric erosive lesions in a mouse model,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 294, no. 4, pp. G877–G884, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. E. Murry, C. M. Giachelli, S. M. Schwartz, and R. Vracko, “Macrophages express osteopontin during repair of myocardial necrosis,” The American Journal of Pathology, vol. 145, no. 6, pp. 1450–1462, 1994. View at Google Scholar · View at Scopus
  28. M. Flück, S. I. Mund, J. C. Schittny, S. Klossner, A.-C. Durieux, and M.-N. Giraud, “Mechano-regulated tenascin-C orchestrates muscle repair,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 36, pp. 13662–13667, 2008. View at Publisher · View at Google Scholar · View at Scopus